Goldman Sachs Asset Management launches new healthcare advisory council

Goldman Sachs Asset Management has formed a new healthcare advisory council. Among those on the council are former Senate Majority Leader Bill Frist; Molly Joseph, former CEO of UnitedHealthcare Global; and Rolf Classon, former chairman of the Executive Committee of Bayer HealthCare AG and president of Bayer Diagnostics. The council will help identify investment opportunities and drive strategic, long-term value creation for portfolio companies.

PRESS RELEASE

NEW YORK, February 18 2022 – Goldman Sachs Asset Management today announced the formation of a new Healthcare Advisory Council to offer external strategic, operational and subject matter expertise for its global private healthcare investing platform.

The Healthcare Advisory Council will operate as part of the Goldman Sachs Value Accelerator, a network of internal and external advisors and resources dedicated to the private investing strategies within Goldman Sachs Asset Management. This centralized platform is a resource for portfolio companies to help build enduring businesses and create incremental value by leveraging the Goldman Sachs network, its differentiated resources, and its highly distinguished operating advisors.

“We are excited to extend our partnerships with top operating executives through the GS Value Accelerator,” said Lou D’Ambrosio, Lead Operating Advisor and head of the Goldman Sachs Value Accelerator. “The Healthcare Advisory Council illustrates the strength of the Goldman Sachs Asset Management platform and our ability to partner with exceptional operating leaders to drive new investment activity and value creation.”

The Heathcare Advisory Council will help to identify attractive investment opportunities and drive strategic, long-term value creation for portfolio companies. “We are excited to partner with industry leading executives from a wide range of backgrounds within healthcare to build enduring businesses,” said Jo Natauri, Partner and Global Head of Private Healthcare Investing within Goldman Sachs Asset Management. “The Healthcare Advisory Council will further differentiate our platform through deep sector expertise in addition to our global network and resources, and we have already accelerated our investment activity in healthcare over the past year alongside members of the council.”

Goldman Sachs Asset Management led 39 healthcare investments in 2021, representing nearly $10 billion of equity and debt capital invested in the sector. The 2021 equity investments include 4G Clinical, Amedes, Aragen Life Sciences, AvaSure, Datavant, eVisit, H1, MDVIP, Mirion Technologies, New Frontier Health and Parexel. The Healthcare Advisory Council will work with GS AMD across the division’s various investment strategies in healthcare.

The Council consists of seven industry executives:

Rolf Classon
Former Chairman of the Executive Committee of Bayer HealthCare AG and President of Bayer Diagnostics
Select current and prior Board experience includes Catalent, Hill-Rom Corporation, Millipore and Fresenius Medical Care

Robert Coury
Executive Chairman of Viatris, created through the merger of Mylan and Pfizer’s Upjohn business; former CEO of Mylan from 2002 to 2012 and Executive Chairman of Mylan from 2012 to 2016
Select current and prior Board experience includes Viatris/Mylan

Meghan FitzGerald
Former CEO/Managing Partner at LetterOne; former EVP of Strategy, M&A and Health Policy and member of the Executive Committee at Cardinal Health; former senior executive at Medco and Pfizer; current Adjunct Associate Professor of Health Policy at Columbia University
Select current and prior Board experience includes Tenet Health, 4G Clinical, Rayus Radiology, ABB Optical, HealthPRO Heritage, Seniorlink, MSD, Arix Bioscience, Destination Pet, K2HV and Parexel (observer)

Bill Frist
Senator Bill Frist, MD represented Tennessee in the U.S. Senate for 12 years; elected Majority Leader of the Senate and served on multiple committees responsible for writing health legislation
20 years of experience in clinical medicine as heart transplant surgeon and founder of the Vanderbilt Multi-Organ Transplant Center (largest heart transplant center in the U.S.)
Select current and prior Board experience includes Accolade, Select Medical and Teladoc

Susannah Gray
Former EVP and CFO of Royalty Pharma
Select current and prior Board experience includes 4D Molecular Therapeutics, Maravai LifeSciences, Apria Healthcare and Morphic Therapeutics

Molly Joseph
Former CEO of UnitedHealthcare Global, representing UnitedHealthcare’s businesses outside the US, and EVP of Global Health at UnitedHealth Group
Select current and prior Board experience includes First Solar and West Pharmaceutical Services

David King
Former Executive Chairman and CEO of LabCorp
Select current and prior Board experience includes Privia, Cardinal Health, Binxhealth and PATH

Goldman Sachs Asset Management led 39 healthcare investments in 2021, representing nearly $10 billion of equity and debt capital invested in the sector. The 2021 equity investments include 4G Clinical, Amedes, Aragen Life Sciences, AvaSure, Datavant, eVisit, H1, MDVIP, Mirion Technologies, New Frontier Health and Parexel. The Healthcare Advisory Council will work with GS AMD across the division’s various investment strategies in healthcare.

About Goldman Sachs Asset Management
Bringing together traditional and alternative investments, Goldman Sachs Asset Management provides clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area within Goldman Sachs (NYSE: GS), we deliver investment and advisory services for the world’s leading institutions, financial advisors and individuals, drawing from our deeply connected global network and tailored expert insights, across every region and market—overseeing more than $2.3 trillion in assets under supervision worldwide as of June 30, 2021. Driven by a passion for our clients’ performance, we seek to build long-term relationships based on conviction, sustainable outcomes, and shared success over time. Goldman Sachs Asset Management invests in the full spectrum of alternatives, including private equity, growth equity, private credit, real estate and infrastructure. We combine our global network of relationships, our unique insight across markets, industries and regions, and the worldwide resources of Goldman Sachs to build businesses and accelerate value creation across our portfolios. Follow us on LinkedIn.

About Goldman Sachs Value Accelerator

The Goldman Sachs Value Accelerator platform delivers robust operating capabilities and insights to our portfolio companies. The Value Accelerator creates enduring business value by leveraging the extended GS network, differentiated resources, and highly distinguished operating advisors. Primary areas of focus for the Value Accelerator include helping portfolio companies scale revenue, build operational excellence, transform digitally, attract and develop top talent, manage risk, and lead in environmental, social and governance (ESG).